UPC APP 5366/2025
EP4201327 Unitary patent · FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Division
- Milan CD
- Judges
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Feb 15, 2025
- EPO Opposition
- EOFlow Co., Ltd.Withdrawn2025-03-18
- KELLER SCHNEIDER PATENTANWALTS GMBHAdmissible2025-03-19
- Inspicos P/SWithdrawn2025-03-19
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Milan CD | Locked |
| Judge Andrea Postiglione | Locked |
At the UPC: Insulet Corporation (25 cases)·EOFLOW Co., Ltd. (19 cases)
This dispute contains 18 other proceedings
UPC CFI 1230/2026·UPC CoA 34/2026·UPC CoA 930/2025·UPC CFI 1167/2025·UPC CFI 773/2025 and 13 more
3 other defendants litigating the same or a related patent
- 2025-02-15
Summary: Procedural order from the Milan section of the Central Division (UPC_CFI_380/2024) on costs in preliminary injunction proceedings. EOFLOW applied for reimbursement of its costs incurred defending against Insulet's rejected preliminary injunction application. The Court ruled that costs of a preliminary phase must be settled at the time of the final merits decision, not parcelled out by procedural stage, and therefore deferred the costs question.
Show the legal issues (3)
- Costs in preliminary injunction proceedings
- Timing of cost compensation
- Interplay between PI proceedings and merits proceedings
- 97614D9B0B9E831E386DF03FF41D523D_en.pdf2025-02-15EN